Poor-quality peptides may contain contaminants, degradation products, or incorrect doses that compromise both safety and results
The zero withdrawal rate in AOD-9604 trials suggests excellent practical tolerability that extends beyond merely counting adverse events to assessing their real impact on treatment continuation
Semaglutide users usually begin experiencing appetite suppression within the first 1 to 2 weeks, with meaningful weight loss becoming visible by weeks 4 to 8 and continuing to progress over the following months
Even simple anaemia affects many organ systems: fatigue, pallor, abdominal complaints, high heart rate, shortness of breath when climbing stairs, and dizziness
If you take metformin regularly, talk to your health professionals about getting screened for vitamin B12 deficiency